Tenon Medical (TNON) Expected to Post Earnings on Thursday

Tenon Medical (NASDAQ:TNON) is anticipated to issue its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect the company to post earnings of ($8.40) per share and revenue of $1.54 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.

Tenon Medical (NASDAQ:TNON) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($10.85) EPS for the quarter, missing the consensus estimate of ($10.68) by ($0.17). The firm had revenue of $1.38 million for the quarter, compared to analysts’ expectations of $1.30 million. Tenon Medical had a negative return on equity of 907.60% and a negative net margin of 270.09%.

Tenon Medical Trading Up 32.0%

TNON opened at $6.05 on Tuesday. The firm’s 50-day moving average price is $12.23 and its 200 day moving average price is $22.01. Tenon Medical has a twelve month low of $4.38 and a twelve month high of $60.90. The firm has a market capitalization of $71.69 million, a PE ratio of -4.69 and a beta of 1.40.

Analyst Ratings Changes

A number of brokerages recently commented on TNON. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a research report on Friday, July 17th. Alliance Global Partners reiterated a “buy” rating on shares of Tenon Medical in a report on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Tenon Medical has a consensus rating of “Hold”.

Institutional Trading of Tenon Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Jane Street Group LLC purchased a new stake in shares of Tenon Medical during the 1st quarter worth approximately $29,000. Geode Capital Management LLC increased its position in shares of Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after purchasing an additional 17,137 shares in the last quarter. Finally, DRW Securities LLC purchased a new stake in shares of Tenon Medical in the 4th quarter valued at about $98,000. 22.74% of the stock is currently owned by institutional investors and hedge funds.

Tenon Medical Company Profile

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.